What type of study is this?

Effectiveness of Different Treatment Regimens for Patients with Newly Diagnosed Pulmonary Tuberculosis Susceptible to Antituberculosis Drugs

View Full Paper

Ask AI

Bookmark

Cessation of bacterial excretion occurred in 100% of patients treated with moxifloxacin and rifapentine.
Radiological changes disappeared in 87.88% of the main group versus 84.38% in the control group.
Weight increased in 51.5% of patients in the main group while 43.75% in control experienced similar results.
The shorter treatment regimen showed 45.44% higher costs though improved patient psychological states.

No takes yet. Share an insight, caveat, or question.

Trial demonstrates improved outcomes in newly diagnosed tuberculosis patients, highlighting the role of moxifloxacin and rifapentine.

Vorodyukhina et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark